Kevin J. Appelbaum

Insider Reports History

Location
Dublin, CA
Signature
/s/ Mark Heinen, Attorney-in-Fact for Kevin J. Appelbaum
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin J. Appelbaum:

Company Role Class Num Shares Value Price $ Report Date Ownership
Better Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 2,406,719 $408,902 $0.1699 31 Mar 2022 By Trust
Better Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 6,250 $1,062 $0.1699 31 Mar 2022 Direct
Better Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Stock Option (Right to Buy) 235,000 01 Apr 2022 Direct

Insider Reports Filed by Kevin J. Appelbaum

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322013342-appelbaum-kevin-j-2022-03-31 Better Therapeutics, Inc. 31 Mar 2022 2 +$4,921 4 Chief Executive Officer, Director, 10%+ Owner 04 Apr 2022, 16:27
/report/000089924321049425-appelbaum-kevin-j-2021-12-20 Better Therapeutics, Inc. 20 Dec 2021 1 +$4,600 4 Chief Executive Officer, Director, 10%+ Owner 22 Dec 2021, 17:03
/report/000089924321048904-appelbaum-kevin-j-2021-12-15 Better Therapeutics, Inc. 15 Dec 2021 1 +$3,530 4 Chief Executive Officer, Director, 10%+ Owner 17 Dec 2021, 19:43
/report/000089924321048151-appelbaum-kevin-j-2021-12-10 Better Therapeutics, Inc. 10 Dec 2021 1 +$5,975 4 Chief Executive Officer, Director, 10%+ Owner 14 Dec 2021, 16:32
/report/000089924321046974-appelbaum-kevin-j-2021-12-02 Better Therapeutics, Inc. 02 Dec 2021 2 +$6,633 4 Chief Executive Officer, Director, 10%+ Owner 06 Dec 2021, 16:34
/report/000089924321042248-appelbaum-kevin-j-2021-10-28 Better Therapeutics, Inc. 28 Oct 2021 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 01 Nov 2021, 20:55